2013 Wisconsin Act 199 (2013-14 Assembly Bill 445): Requires individuals to show proper identification when picking up schedule II or III narcotic/opiate prescription medication in order to address prescription fraud and diversion.


2013 Wisconsin Act 200 (2013-14 Assembly Bill 446): Provides all levels of EMTs, first responders, police and fire the ability to be trained to administer Naloxone Narcan, a drug used to counter the effects of opiate overdose, such as a heroin overdose. Any person who administers the drug is immune from civil or criminal liability provided their actions are consistent with Wisconsin’s Good Samaritan law.


2013 Wisconsin Act 194 (2013-14 Assembly Bill 447): Provides limited immunity from certain criminal prosecutions for a person who seeks assistance from the police or medical professionals for another individual who has overdosed on controlled substances.


2013 Wisconsin Act 198 (2013-14 Assembly Bill 448): Encourages communities to set up drug disposal programs and regulates these programs so unwanted prescription drugs do not fall into the wrong hands.


2013 Wisconsin Act 197 (2013-14 Assembly Bill 668): Expands Treatment Alternatives and Diversion (TAD) programs by increasing funding by $1.5 million annually. Administered by the county, TAD has proven to be an effective and efficient means of combatting drug and alcohol abuse in our state.


2013 Wisconsin Act 195 (2013-14 Assembly Bill 701): Creates regional pilot programs to address opiate addiction in underserved areas. The treatment programs will assess individuals to determine treatment needs, provide counseling, and medical or abstinence-based treatment. After individuals successfully complete the program, they will be transitioned into county-based or private post-treatment care.


2013 Wisconsin Act 196 (2013-14 Assembly Bill 702): Creates a system of immediate punishments for individuals who violate their parole or probation parolees based on so-called “swift and certain” laws in other states. The model is based on research that shows that it’s the swiftness and the certainty of the sanction, not the length of the confinement, which has the greatest impact on influencing an offender’s behavior.


2015 Wisconsin Act 115 (2015-16 Assembly Bill 427): Expands Wisconsinites’ access to opioid antagonists like Narcan by offering the drug for purchase from certain pharmacies without a prescription via standing order.


2015 Wisconsin Act 266 (2015-16 Assembly Bill 364): Changes the requirement for those who dispense certain prescription drugs to submit information to the PDMP from 7 days to 24 hours. It will also require a practitioner to review a patient’s record when initially prescribing a monitored prescription drug (for example, a Schedule II drug).


2015 Wisconsin Act 268 (2015-16 Assembly Bill 365): States that when law enforcement encounters an inappropriate use or an infraction of the law concerning scheduled drugs, they upload that information into the PDMP and have the PDMP notify the physician. There are exceptions for on-going investigations.


2015 Wisconsin Act 265 (2015-16 Assembly Bill 366): Gives the Department of Health Services (DHS) oversight over the operation of pain management clinics across the state. The department’s oversight would not be regulatory, but would be a way of providing safeguards so “pill mills” don’t pop up in our state.


2015 Wisconsin Act 262 (2015-16 Assembly Bill 367): Requires methadone clinics to gather data such as staffing ratios, the number of patients receiving behavioral health services with the medication, and average mileage an individual is traveling to come to a clinic. This information will then be reported to DHS on an annual basis to give public health and treatment professionals a chance to analyze outcome data.


2015 Wisconsin Act 338 (2015-16 Assembly Bill 657): Allocates $2 million each fiscal year to go toward Treatment and Diversion (TAD) programs. These programs are alternatives for individuals charged with certain crimes to prosecution and incarceration. The individuals enrolled in the program will have the chance to receive the help and support they need in order to become and remain contributing members of society.


2015 Wisconsin Act 264 (2015-16 Assembly Bill 658): Criminalizes the use, possession, manufacture, distribution, and advertisement of any substance or device that is intended to defraud, circumvent, interfere with, or provide a substitute for a bodily fluid in conjunction with a lawfully administered drug test. Given that many employers subject their employees to lawfully administered drug tests, this bill will help ensure that people are not defrauding or interfering with the test results.


2015 Wisconsin Act 263 (2015-16 Assembly Bill 659): State regulations regarding opioid treatment programs are much more stringent than federal regulations. In order to afford more people accessibility to the treatment they need, this bill streamlines Wisconsin’s state regulations to align with federal regulations. With these changes, more Wisconsinites will be able to have access to opioid treatment.


2015 Wisconsin Act 269 (2015-16 Assembly Bill 660): Allows a number of medical-affiliated boards under the Department of Safety and Professional Services (DSPS) to issue guidelines regarding best practices in prescribing controlled substances. These best practices will help reduce instances of overprescribing and, in turn, lessen prescription opioid misuse, abuse, and addiction.


2015 Wisconsin Act 267 (2015-16 Assembly Bill 766): Creates reporting requirements for the Prescription Drug Monitoring Program (PDMP).The data collected will be reviewed and evaluated by the Controlled Substances Board (CSB) to determine the effectiveness of the PDMP and to compare actual outcomes with projected outcomes.


2017 Wisconsin Act 29 (2017 Special Session Assembly Bill 1): Schools are often the center of our communities, and this bill helps to ensure the safety of all who visit our local schools. Currently, school personnel are allowed to administer certain life-saving drugs to students in compliance with written instructions from a practitioner.  This bill allows school personnel with the proper training to administer an opioid antagonist if a person on school grounds is experiencing an overdose. These lifesaving drugs include epinephrine (epi-pen) for treating an allergic reaction, and glucagon for students who suffer from diabetes. An amendment to this bill allows for residence hall directors at UW-System institutions, technical colleges, and private colleges to administer an opioid antagonist.


2017 Wisconsin Act 32 (2017 Special Session Assembly Bill 2): Treatment and Diversion (TAD) grants are awarded by the Department of Justice to counties that offer alternatives to prosecution and incarceration – like drug courts – for individuals charged with certain drug-related crimes.  This bill allocates additional funding for TAD programs to expand TAD to new counties, and for a pre-booking diversion pilot program.



2017 Wisconsin Act 33 (2017 Special Session Assembly Bill 3): According to a study by The Network for Public Health Law, 88 percent of drug users surveyed indicated that they would be more likely to summon emergency personnel during an overdose if the state enacted a Good Samaritan law. As of January of this year, 37 states and the District of Columbia have enacted some form of a Good Samaritan or 911 drug immunity law. Current law offers limited immunity from prosecution for certain drug-related offenses to a person who summons emergency personnel in the event of another person’s overdose. This bill expands upon current law to offer the same limited immunity to the person who is overdosing.


2017 Wisconsin Act 25 (2017 Special Session Assembly Bill 4): Majority of states don’t allow codeine cough syrups to be purchased over the counter (OTC). In Wisconsin, however, these medications are available without a prescription. This bill requires a prescription to obtain certain Schedule V medications, like codeine cough syrups and will help ensure these potentially dangerous medications are less accessible to those looking to misuse/abuse them.



2017 Wisconsin Act 34 (2017 Special Session Assembly Bill 5): Alcoholism and drug addiction should be treated similarly in circumstances when an individual is a danger to his/herself or others. This bill allows for the same treatment of alcohol addiction as drug addiction: 3 petitioners, Court proceedings, and a 72 hour hold. This bill also fits in tandem with the Good Samaritan expansion – if a person suffers an overdose, he/she may be taken out of active use through emergency detention.



2017 Wisconsin Act 30 (2017 Special Session Assembly Bill 6): This recovery school is an alternative to a student’s residential school and will offer high school aged students who have struggled with addiction an opportunity at long-term recovery while continuing their high school education. The school will offer mental health and therapy supports to encourage students to continue on the path to recovery. This bill is based on proven national recovery school models, utilizes a braided funding structure, and is capped at 15 students during the pilot phase to ensure every student gets the support they need to succeed.



2017 Wisconsin Act 26 (2017 Special Session Assembly Bill 7): Currently graduate training and fellowships are not widely available in addiction medicine, yet due to rapid growing opioid epidemic, addiction medicine specialists are in high demand. This bill allocates funding for additional addiction medication fellowships in Wisconsin to better assist with the increasing case workload.



2017 Wisconsin Act 27 (2017 Special Session Assembly Bill 8): Due to an increasing addiction epidemic, there is a high need for addiction treatment services. Previous law created 3 regional treatment facilities in rural and underserved areas including: NorthLakes Community Clinic (serving northwest WI), Northeast Wisconsin Opioid Treatment Services (Marinette area/Libertas), and HOPE Consortium (between northeast and northwest facilities). This bill allocates funding to establish more regional treatment facilities in underserved areas.


2017 Wisconsin Act 28 (2017 Special Session Assembly Bill 9): This bill provides a Doctor-to-Doctor Consultation program modeled after the Child Psychiatry Consultation Program (CPCP) at the Medical College of Wisconsin. This program will act as a resource for doctors who aren’t well versed in addiction medicine to be in consultation with other doctors who can suggest addiction treatment best practices.


2017 Wisconsin Act 35 (2017 Special Session Assembly Bill 10): Often times, people who become addicted to opioids inevitably turn to drugs like heroin when prescription medications become too expensive or difficult to obtain. These positions will function in tandem with the DEA to focus solely on stopping drug trafficking into Wisconsin by allocating funding for 4 new DOJ positions to fight drug trafficking.


2017 Wisconsin Act 31 (2017 Special Session Assembly Bill 11): Often times, students don’t feel comfortable going to a teacher or school administrator with questions about drugs or alcohol. However, data shows that access to counselors has a positive impact on the lives of students who may be at risk for substance abuse disorders. This bill allocates funding for a program called Screening, Brief Intervention, and Referral to Treatment (SBIRT), where students will have access to trained counselors should they have any concerns about substance use, abuse, and addiction.


2017 Wisconsin Act 261 (2017-18 Assemby Bill 906): This bill contains provides additional funding for Law-Enforcement Drug Trafficking Grants, evidence-based programs, and an expansion of family drug courts. This bill also provides two additional full time drug prosecutors to assist northern Wisconsin District Attorneys, enables judges to utilize Victim Impact Panels as a sentence option, and provides grants to be used by county jails to provide a non narcotic, non-addictive, injectable medically assisted treatment to inmates who will be released into the community within five days of receiving the treatment and who volunteer 


2017 Wisconsin Act 262 (2017-18 Assembly Bill 907): This bill focuses its efforts on expansion of education and training. Specifically, the bill provides funding to DCF (Dept of Children and Families) to develop and maintain training materials, provides additional funds to expand Graduate Nurse education, specifies controlled substances are to be included in instructional requirements in schools and their effects on the human system, and expand substance abuse counseling to our most vulnerable citizens in the state.

The bill also focuses makes several changes to requirements currently in place for prescribers. Specifically, the bill requires each regulatory board overseeing professions that can prescribe controlled substances to submit a report to the Governor’s Task Force on Opioid Abuse and standing Health Committees detailing the proactive efforts it has taken to address the opioid abuse, as well as require DHS to review its prior authorization policy on buprenorphine-containing products, one of three medications approved by the FDA to treat people with opioid use disorder (OUD), provided to MA recipients and submit a request DHS with their findings.